Completed PHASE4 INTERVENTIONAL 3-arm NCT02507635

Anti-inflammatory H1 Antihistamines Allergic Rhinitis

In Vivo Anti-inflammatory Effect of H1 Antihistamines in Allergic Rhinitis

Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy

Interventions Desloratadine Levocetirizine

Updated 5 times since 2017 Last updated: Jul 22, 2015 Started: Feb 28, 2009 Primary completion: Nov 30, 2011 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Allergic Rhinitis, this trial is completed. The trial is conducted by Iuliu Hatieganu University of Medicine and Pharmacy and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Iuliu Hatieganu University of Medicine and Pharmacy

Data source: Iuliu Hatieganu University of Medicine and Pharmacy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.